Neuphoria Therapeutics's total assets for Q2 2026 were AU$36.60M, an increase of 33.84% from the previous quarter. NEUP total liabilities were AU$6.90M for the fiscal quarter, a -53.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.